CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Expenses
Accounting and audit	$ 11,183	$ (4,419)	$ 37,338	$ 45,131
Consulting	53,274	30,752	143,332	132,496
Fees and dues	42,213	39,651	53,363	80,085
Investor relations	4,311	12,812	22,180	52,454
Legal and professional	14,396	7,259	56,628	81,603
Office and miscellaneous	15,577	31,168	50,829	85,929
Mineral exploration costs	7,080	421,716	57,444	429,751
Research and development	21,883	45,072	130,678	102,424
Total expenses	169,917	584,011	551,792	1,009,873
Loss for the period before other items	(169,917)	(584,011)	(551,792)	(1,009,873)
Other income (expense)
Foreign exchange gain (loss)	(1,417)	(1,379)	786	(3,736)
Realized loss on marketable securities	(243,560)	(204,637)	(969,873)	(327,378)
Realized foreign exchange loss on marketable securities	(14,451)	(19,134)	(53,474)	(30,537)
Unrealized loss on marketable securities	161,362	(324,529)	742,493	222,779
Unrealized foreign exchange gain (loss) on marketable securities	(19,918)	(5,705)	(13,373)	(142,420)
Net loss for the period	(287,901)	(1,139,395)	(845,233)	(1,291,165)
Net loss attributable to:
Common shareholders	(287,849)	(1,139,103)	(844,759)	(1,290,776)
Non controlling interest	$ (52)	$ (292)	$ (474)	$ (389)
Basic loss per share	$ (0)	$ (0.01)	$ (0.01)	$ (0.01)
Diluted loss per share	$ (0)	$ (0.01)	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding - Basic	155,166,088	155,166,088	155,166,088	155,135,136
Weighted average number of common shares outstanding - Diluted	155,166,088	155,166,088	155,166,088	155,135,136